Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Average Recommendation of “Hold” by Analysts
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Free Report) have been assigned a consensus recommendation of “Hold” from the five analysts that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12 […]
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Free Report) have been assigned a consensus recommendation of “Hold” from the five analysts that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12 […]
